Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

P Kanellopoulos, A Kaloudi, Marion Jong, Eric Krenning, BA Nock, T Maina

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

3 Downloads (Pure)

Access to Document

@article{271de17720c94016acfd1a88881279db,

title = "Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands",

author = "P Kanellopoulos and A Kaloudi and Marion Jong and Eric Krenning and BA Nock and T Maina",

year = "2020",

doi = "10.3390/pharmaceutics12060528",

language = "English",

volume = "12",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "6",

}

TY - JOUR

T1 - Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

AU - Kanellopoulos, P

AU - Kaloudi, A

AU - Jong, Marion

AU - Krenning, Eric

AU - Nock, BA

AU - Maina, T

PY - 2020

Y1 - 2020

U2 - 10.3390/pharmaceutics12060528

DO - 10.3390/pharmaceutics12060528

M3 - Article

SN - 1999-4923

VL - 12

JO - Pharmaceutics

JF - Pharmaceutics

IS - 6

M1 - 528

ER -